amikin 250 %v/v solution for injection
bristol-myers squibb (holdings) limited - amikacin sulfate - solution for injection - 250 %v/v
amikin
bristol-myers squibb (nz) limited - amikacin sulfate equivalent to 250 mg/ml of amikacin - solution for injection - 500 mg/2ml - active: amikacin sulfate equivalent to 250 mg/ml of amikacin excipient: sodium bisulfite sodium citrate dihydrate sulfuric acid water for injection
amikacin solvent for parenteral use 250mg/ml mg/ml
hospira uk ltd - amikacin sulfate - solvent for parenteral use - 250mg/ml mg/ml
amikacin - fresenius 1g/4ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 4ml of solution contains:amikacin sulphate equivalent to amikacin 1g
amikacin - fresenius 100mg/2ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml of vial contains:amikacin sulphate equivalent to amikacin 100 mg
amikacin - fresenius 250mg/2ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml vial contains:amikacin sulphate equivalent to amikacin 250mg
amikacin - fresenius 500mg/2ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml vial contains:amikacin sulphate equivalent to amikacin 500mg
arikayce liposomal 590 mg
truemed ltd, israel - amikacin as sulfate - suspension for inhalation - amikacin as sulfate 70 mg/ml - amikacin - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis. consideration should be given to official guidance on the appropriate use of antibacterial agents.
akacin solution for injection
amikacin sulfate injection usp 500mg/2ml - solution for injection - 500mg/2ml - amikacin
mica 500mg injection
brawn laboratories ltd. 13, new industrial township faridabad,121001 - amikacin sulfate usp - injection - 500 mg/2ml - amikacin